Based on the Hologic Inc stock forecast from 10 analysts, the average analyst target price for Hologic Inc is USD 86.35 over the next 12 months. Hologic Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Hologic Inc is Bullish , which is based on 8 positive signals and 3 negative signals. At the last closing, Hologic Inc’s stock price was USD 70.37. Hologic Inc’s stock price has changed by +0.24% over the past week, -1.79% over the past month and -4.96% over the last year.
No recent analyst target price found for Hologic Inc
No recent average analyst rating found for Hologic Inc
Company Overview Hologic Inc
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts. Read Less
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GY...Read More
Frequently Asked Questions About Hologic Inc (HOLX) Stock
Based on ratings from 10 analysts Hologic Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Bullish . The stock has 9 buy, sell and 8 hold ratings.
Unfortunately we do not have enough data on HOLX's stock to indicate if its a good dividend stock.
Based on targets from 10 analysts, the average taret price for HOLX is USD 86.35 over the next 12 months. The maximum analyst target price is USD 95 while the minimum anlayst target price is USD 76.
HOLX stock's Price/Earning ratio is 22.05.
Our analysis grades HOLX stock's Price / Earning ratio at D+. This means that HOLX stock's Price/Earning ratio is above 32.99999999999999% of the stocks in the Medical Instruments & Supplies sector in the NSD exchange.
Based on this HOLX may be fairly valued for its sector
The last closing price of HOLX's stock was USD 70.37.
The most recent market capitalization for HOLX is USD 16.61B.
Based on targets from 10 analysts, the average taret price for HOLX is projected at USD 86.35 over the next 12 months.
This means that HOLX's stock price may go up by +22.71% over the next 12 months.
We can't find any ETFs which contains Hologic Inc's stock.
As per our most recent records Hologic Inc has 6,990 Employees.
Hologic Inc's registered address is 250 Campus Drive, Marlborough, MA, United States, 01752.
You can get more information about it from Hologic Inc's website at https://www.hologic.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Hologic Inc (HOLX) Stock
Based on ratings from 10 analysts Hologic Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Bullish . The stock has 9 buy, sell and 8 hold ratings.
Unfortunately we do not have enough data on HOLX's stock to indicate if its a good dividend stock.
Based on targets from 10 analysts, the average taret price for HOLX is USD 86.35 over the next 12 months. The maximum analyst target price is USD 95 while the minimum anlayst target price is USD 76.
HOLX stock's Price/Earning ratio is 22.05.
Our analysis grades HOLX stock's Price / Earning ratio at D+. This means that HOLX stock's Price/Earning ratio is above 32.99999999999999% of the stocks in the Medical Instruments & Supplies sector in the NSD exchange.
Based on this HOLX may be fairly valued for its sector
The last closing price of HOLX's stock was USD 70.37.
The most recent market capitalization for HOLX is USD 16.61B.
Based on targets from 10 analysts, the average taret price for HOLX is projected at USD 86.35 over the next 12 months.
This means that HOLX's stock price may go up by +22.71% over the next 12 months.
We can't find any ETFs which contains Hologic Inc's stock.
As per our most recent records Hologic Inc has 6,990 Employees.
Hologic Inc's registered address is 250 Campus Drive, Marlborough, MA, United States, 01752.
You can get more information about it from Hologic Inc's website at https://www.hologic.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for HOLX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
